AT356078B - Verfahren zur herstellung neuer acetohydroxam- saeuren und deren salze - Google Patents
Verfahren zur herstellung neuer acetohydroxam- saeuren und deren salzeInfo
- Publication number
- AT356078B AT356078B AT193077A AT193077A AT356078B AT 356078 B AT356078 B AT 356078B AT 193077 A AT193077 A AT 193077A AT 193077 A AT193077 A AT 193077A AT 356078 B AT356078 B AT 356078B
- Authority
- AT
- Austria
- Prior art keywords
- salts
- producing new
- acetohydroxamic acids
- acids
- new acetohydroxamic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D295/145—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/15—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C275/30—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by halogen atoms, or by nitro or nitroso groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
- C07C57/64—Acyl halides
- C07C57/72—Acyl halides containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D223/18—Dibenzazepines; Hydrogenated dibenzazepines
- C07D223/22—Dibenz [b, f] azepines; Hydrogenated dibenz [b, f] azepines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/72—Two oxygen atoms, e.g. hydantoin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/72—Two oxygen atoms, e.g. hydantoin
- C07D233/74—Two oxygen atoms, e.g. hydantoin with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to other ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/72—Two oxygen atoms, e.g. hydantoin
- C07D233/76—Two oxygen atoms, e.g. hydantoin with substituted hydrocarbon radicals attached to the third ring carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C07D235/16—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
- C07D279/10—1,4-Thiazines; Hydrogenated 1,4-thiazines
- C07D279/14—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems
- C07D279/18—[b, e]-condensed with two six-membered rings
- C07D279/22—[b, e]-condensed with two six-membered rings with carbon atoms directly attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
- C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
- C07D317/56—Radicals substituted by sulfur atoms
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB11710/76A GB1574822A (en) | 1976-03-23 | 1976-03-23 | Acetohydroxamic acid derivatives and pharmaceutical compositions thereof |
GB629877 | 1977-02-15 |
Publications (2)
Publication Number | Publication Date |
---|---|
ATA193077A ATA193077A (de) | 1979-09-15 |
AT356078B true AT356078B (de) | 1980-04-10 |
Family
ID=26240593
Family Applications (5)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT193077A AT356078B (de) | 1976-03-23 | 1977-03-21 | Verfahren zur herstellung neuer acetohydroxam- saeuren und deren salze |
AT839978A AT358556B (de) | 1976-03-23 | 1978-11-24 | Verfahren zur herstellung neuer aralkylsul- finyl-acetohydroxamsaeuren und deren salzen |
AT0840078A AT362793B (de) | 1976-03-23 | 1978-11-24 | Verfahren zur herstellung neuer ureido-acetohydroxamsaeuren und deren metallsalzen |
AT839878A AT361932B (de) | 1976-03-23 | 1978-11-24 | Verfahren zur herstellung von neuen piperazin-1 -yl-acethydroxamsaeuren und deren salzen |
AT0501480A AT374191B (de) | 1976-03-23 | 1980-10-09 | Verfahren zur herstellung von neuen substituierten acethydroxamsaeuren und deren salzen |
Family Applications After (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT839978A AT358556B (de) | 1976-03-23 | 1978-11-24 | Verfahren zur herstellung neuer aralkylsul- finyl-acetohydroxamsaeuren und deren salzen |
AT0840078A AT362793B (de) | 1976-03-23 | 1978-11-24 | Verfahren zur herstellung neuer ureido-acetohydroxamsaeuren und deren metallsalzen |
AT839878A AT361932B (de) | 1976-03-23 | 1978-11-24 | Verfahren zur herstellung von neuen piperazin-1 -yl-acethydroxamsaeuren und deren salzen |
AT0501480A AT374191B (de) | 1976-03-23 | 1980-10-09 | Verfahren zur herstellung von neuen substituierten acethydroxamsaeuren und deren salzen |
Country Status (25)
Country | Link |
---|---|
US (7) | US4122186A (de) |
JP (1) | JPS52144601A (de) |
AT (5) | AT356078B (de) |
AU (1) | AU516473B2 (de) |
BE (1) | BE852738A (de) |
CA (2) | CA1120928A (de) |
CH (1) | CH620894A5 (de) |
CS (1) | CS200511B2 (de) |
DD (1) | DD129645A5 (de) |
DE (1) | DE2711451A1 (de) |
DK (1) | DK171197B1 (de) |
ES (1) | ES457105A1 (de) |
FI (1) | FI62821C (de) |
FR (4) | FR2345430A1 (de) |
GB (1) | GB1574822A (de) |
IE (1) | IE44721B1 (de) |
IL (1) | IL51705A (de) |
LU (1) | LU76989A1 (de) |
NL (1) | NL188801C (de) |
NO (4) | NO144420C (de) |
NZ (1) | NZ183616A (de) |
PH (1) | PH16271A (de) |
PT (1) | PT66300B (de) |
SE (4) | SE432420B (de) |
SU (1) | SU689617A3 (de) |
Families Citing this family (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1584462A (en) * | 1977-03-31 | 1981-02-11 | Lafon Labor | N-diaryl-malonamide and diarylmethyl-sulphinyl-acetamide derivatives and pharmaceutical compositions containing them |
US4405357A (en) | 1980-06-02 | 1983-09-20 | Fmc Corporation | Herbicidal 3-isoxazolidinones and hydroxamic acids |
FR2502617B1 (de) * | 1981-03-25 | 1984-04-27 | Lafon Labor | |
FR2528041A1 (fr) * | 1982-06-04 | 1983-12-09 | Lafon Labor | Acides halogenobenzhydrylsulfinylacetohydroxamiques, procede de preparation et utilisation en therapeutique |
JPS59222454A (ja) * | 1983-05-31 | 1984-12-14 | Ajinomoto Co Inc | アミノ酸の製造方法 |
US4604407A (en) * | 1985-04-04 | 1986-08-05 | E. R. Squibb & Sons, Inc. | Hydroxamates |
FR2584666B1 (fr) * | 1985-07-10 | 1989-06-16 | Champion Spark Plug Europ | Bras moteur pour balai d'essuie-glace avec capuchon coulissant |
FR2585699B1 (fr) * | 1985-07-31 | 1988-03-11 | Lafon Labor | Derive d'acide acetohydroxamique, procede de preparation et utilisation en therapeutique |
US5036157A (en) * | 1986-03-11 | 1991-07-30 | Burroughs Wellcome Co. | Aryl derivatives |
FR2601673B2 (fr) * | 1986-07-21 | 1989-06-02 | Lafon Labor | Derives de l'acetamide et medicaments qui en contiennent |
US4983567A (en) * | 1987-03-16 | 1991-01-08 | Biomeasure, Inc. | Immunomodulators and methods of making same |
ES2011588A6 (es) * | 1989-05-29 | 1990-01-16 | Vinas Lab | Procedimiento para la preparacion de un nuevo derivado fenilacetico. |
JPH0359402U (de) * | 1989-10-13 | 1991-06-12 | ||
US5283248A (en) * | 1989-11-21 | 1994-02-01 | Hoffmann-La Roche Inc. | Amino substituted pyrimido[1,6-2]benzimidazoles |
CA2028530A1 (en) * | 1989-11-21 | 1991-05-22 | Christian Hubschwerlen | Substituted pyrimidobenzimidazole derivatives |
US5378701A (en) * | 1991-12-27 | 1995-01-03 | Kyowa Hakko Kogyo | Tricyclic compounds |
US6060477A (en) * | 1995-06-07 | 2000-05-09 | Cell Pathways, Inc. | Method of treating a patient having precancerous lesions with phenyl cycloamino pyrimidinone derivatives |
US6172057B1 (en) | 1997-02-27 | 2001-01-09 | American Cyanamid Company | N-Hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
DE69823019T2 (de) * | 1997-02-27 | 2005-03-31 | Wyeth Holdings Corp. | N-hydroxy-2-(alkyl, aryl oder heteroaryl sulfanyl, sulfinyl oder sulfonyl)-3-substituierte alkyl-, aryl- oder heteroarylamide als matrixmetalloproteinaseinhibitoren |
US6187924B1 (en) * | 1997-11-12 | 2001-02-13 | Darwin Discovery, Ltd. | Hydroxamic and carboxylic acid derivatives having MMP and TNF inhibitory activity |
PE20001566A1 (es) | 1999-03-26 | 2001-02-05 | Ucb Sa | Piperazinas 1,4-sustituidas, piperidinas 1,4-sustituidas y 4-alquilidenilpiperidinas 1-sustituidas |
US6686502B1 (en) | 1999-03-26 | 2004-02-03 | Ucb S.A. | Compounds and methods for treatment of asthma, allergy and inflammatory disorders |
GB9911071D0 (en) * | 1999-05-12 | 1999-07-14 | Darwin Discovery Ltd | Hydroxamic and carboxylic acid derivatives |
EP1461308B1 (de) * | 2001-12-04 | 2006-12-20 | De Novo Pharmaceuticals Ltd. | Bakterielle enzyminhibitoren |
DE10320453A1 (de) * | 2003-05-08 | 2004-11-25 | Morphochem AG Aktiengesellschaft für kombinatorische Chemie | Neue Bioisostere von Actinonin |
EP1644323B1 (de) * | 2003-07-07 | 2015-03-18 | Georgetown University | Histondeacetylaseinhibitoren und verfahren zu deren anwendung |
US7842835B2 (en) * | 2003-07-07 | 2010-11-30 | Georgetown University | Histone deacetylase inhibitors and methods of use thereof |
US7417040B2 (en) * | 2004-03-01 | 2008-08-26 | Bristol-Myers Squibb Company | Fused tricyclic compounds as inhibitors of 17β-hydroxysteroid dehydrogenase 3 |
US7378426B2 (en) * | 2004-03-01 | 2008-05-27 | Bristol-Myers Squibb Company | Fused heterotricyclic compounds as inhibitors of 17β-hydroxysteroid dehydrogenase 3 |
WO2007134169A2 (en) * | 2006-05-10 | 2007-11-22 | Nuada, Llc | Indole, benzimidazole, and benzolactam boronic acid compounds, analogs thereof and methods of use thereof |
US20090264384A1 (en) * | 2004-11-01 | 2009-10-22 | Nuada, Inc. | Indole, benzimidazole, and benzolactam boronic acid compounds, analogs thereof and methods of use thereof |
WO2007113644A2 (en) * | 2006-04-05 | 2007-10-11 | Orchid Research Laboratories Limited | New hdac inhibitors |
EP2041088B1 (de) | 2006-06-28 | 2014-01-08 | Amgen Inc. | Inhibitoren des glycintransporters 1 |
KR20090064400A (ko) * | 2006-09-28 | 2009-06-18 | 머크 앤드 캄파니 인코포레이티드 | Hdac 억제제 및 킬레이트화 가능한 금속 화합물 및 금속-hdac 억제제 킬레이트 착물의 약제학적 조성물 |
KR101312993B1 (ko) * | 2006-10-28 | 2013-11-25 | 엔비보 파마슈티칼즈, 인코퍼레이티드 | 히스톤 데아세틸라아제의 억제제 |
WO2008094592A1 (en) * | 2007-02-01 | 2008-08-07 | Panthera Biopharna, Llc | Hydroxamic acid derivatives of aniline useful as therapeutic agents for treating anthrax poisoning |
FR2957492B1 (fr) | 2010-03-18 | 2013-08-16 | Rhodia Operations | Nouvelles utilisations de composes de type esteramide |
CN101982459A (zh) * | 2010-10-21 | 2011-03-02 | 山东华尔康生物技术有限公司 | 乙酰氧肟酸的制备工艺 |
GB201509663D0 (en) * | 2015-06-03 | 2015-07-15 | Johnson Matthey Plc | Benzo(h)quinoline ligands and complexes thereof |
US11993575B1 (en) | 2023-12-29 | 2024-05-28 | King Faisal University | Ethyl [4,4-bis(4-bromophenyl)-2,5-dioxoimidazolidin-1-yl]acetate as an antimicrobial compound |
US11970462B1 (en) | 2024-01-03 | 2024-04-30 | King Faisal University | Ethyl 3-[4,4-bis(4-chlorophenyl)-2,5-dioxoimidazolidin-1-yl]propanoate as an antimicrobial compound |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2862020A (en) * | 1958-11-25 | Derivatives of a-amino-p-hydroxy | ||
US2279560A (en) * | 1940-05-08 | 1942-04-14 | Du Pont | Viscous hydrocarbon oil |
US2397508A (en) * | 1943-05-29 | 1946-04-02 | Standard Oil Co | Hydroxamic acids |
GB894119A (en) * | 1959-11-02 | 1962-04-18 | Ici Ltd | Pivalic acid derivative |
US3275643A (en) * | 1963-07-19 | 1966-09-27 | Irwin I Lubowe | Allantoin-pantothenate compounds |
US3634509A (en) * | 1966-06-08 | 1972-01-11 | Shell Oil Co | 2 6-dinitroanilinoacetamides |
NL6715600A (de) * | 1966-12-02 | 1968-06-04 | ||
US3927092A (en) * | 1968-06-24 | 1975-12-16 | Merck & Co Inc | Amides of 2-{8 halophenoxy (or halophenylthio){9 -alkanoic acids |
DE1805548A1 (de) * | 1968-10-26 | 1970-10-08 | Agfa Gevaert Ag | Benzimidazol-Derivate und ihre photographische Verwendung |
FR2036953A1 (en) * | 1969-04-23 | 1970-12-31 | Pluripharm | Diphenylhydantoin derivs |
US4092430A (en) * | 1970-09-09 | 1978-05-30 | Ciba-Geigy Corporation | Antiphlogistic phenylacetohydroxamic acid compositions |
US3728380A (en) * | 1971-05-17 | 1973-04-17 | Morton Norwich Products Inc | P-chlorobenzamidoacetohydroxamic acid |
US3839580A (en) * | 1972-08-14 | 1974-10-01 | Morton Norwich Products Inc | 2-p-(nitrobenzamido)acetohydroxamic for treating urinary tract infections |
SE7411007L (de) * | 1973-10-10 | 1975-04-11 | Ciba Geigy Ag | |
JPS51102636A (en) * | 1974-04-03 | 1976-09-10 | Fuji Photo Film Co Ltd | Karaashashingazo no keiseihoho |
FR2285867A1 (fr) * | 1974-09-30 | 1976-04-23 | Lafon Labor | Derives du diphenylsulfoxyde |
CH593954A5 (de) * | 1975-07-21 | 1977-12-30 | Ciba Geigy Ag | |
US4029812A (en) * | 1976-02-18 | 1977-06-14 | The Dow Chemical Company | Novel hypolipidemic 2-(3,5-di-tert-butyl-4-hydroxyphenyl)thio carboxamides |
-
1976
- 1976-03-23 GB GB11710/76A patent/GB1574822A/en not_active Expired
-
1977
- 1977-03-08 PH PH19538A patent/PH16271A/en unknown
- 1977-03-09 FR FR7706997A patent/FR2345430A1/fr active Granted
- 1977-03-14 PT PT66300A patent/PT66300B/pt unknown
- 1977-03-15 IE IE561/77A patent/IE44721B1/en not_active IP Right Cessation
- 1977-03-16 DE DE19772711451 patent/DE2711451A1/de active Granted
- 1977-03-16 NZ NZ183616A patent/NZ183616A/xx unknown
- 1977-03-17 AU AU23344/77A patent/AU516473B2/en not_active Expired
- 1977-03-17 US US05/778,543 patent/US4122186A/en not_active Expired - Lifetime
- 1977-03-18 FI FI770859A patent/FI62821C/fi not_active IP Right Cessation
- 1977-03-21 CH CH347977A patent/CH620894A5/fr not_active IP Right Cessation
- 1977-03-21 AT AT193077A patent/AT356078B/de not_active IP Right Cessation
- 1977-03-21 LU LU76989A patent/LU76989A1/xx unknown
- 1977-03-21 IL IL51705A patent/IL51705A/xx unknown
- 1977-03-22 SE SE7703263A patent/SE432420B/xx not_active IP Right Cessation
- 1977-03-22 BE BE175998A patent/BE852738A/xx not_active IP Right Cessation
- 1977-03-22 NO NO771006A patent/NO144420C/no unknown
- 1977-03-22 DK DK126677A patent/DK171197B1/da not_active IP Right Cessation
- 1977-03-22 ES ES457105A patent/ES457105A1/es not_active Expired
- 1977-03-22 CA CA000274470A patent/CA1120928A/en not_active Expired
- 1977-03-22 CS CS771904A patent/CS200511B2/cs unknown
- 1977-03-23 JP JP3201177A patent/JPS52144601A/ja active Granted
- 1977-03-23 NL NLAANVRAGE7703168,A patent/NL188801C/xx not_active IP Right Cessation
- 1977-03-23 SU SU772465454A patent/SU689617A3/ru active
- 1977-03-23 DD DD7700198023A patent/DD129645A5/de unknown
-
1978
- 1978-08-04 US US05/930,927 patent/US4151300A/en not_active Expired - Lifetime
- 1978-08-04 US US05/930,926 patent/US4152458A/en not_active Expired - Lifetime
- 1978-08-04 US US05/930,925 patent/US4183951A/en not_active Expired - Lifetime
- 1978-08-04 US US05/930,924 patent/US4209523A/en not_active Expired - Lifetime
- 1978-08-04 US US05/930,928 patent/US4209524A/en not_active Expired - Lifetime
- 1978-11-24 AT AT839978A patent/AT358556B/de not_active IP Right Cessation
- 1978-11-24 AT AT0840078A patent/AT362793B/de not_active IP Right Cessation
- 1978-11-24 AT AT839878A patent/AT361932B/de not_active IP Right Cessation
-
1979
- 1979-08-24 US US06/069,254 patent/US4225617A/en not_active Expired - Lifetime
-
1980
- 1980-03-13 FR FR8005646A patent/FR2453158A1/fr active Granted
- 1980-03-13 FR FR8005644A patent/FR2453148A1/fr active Granted
- 1980-03-13 FR FR8005645A patent/FR2453133A1/fr active Granted
- 1980-10-09 AT AT0501480A patent/AT374191B/de not_active IP Right Cessation
- 1980-11-06 NO NO803337A patent/NO152972C/no unknown
- 1980-11-06 NO NO803338A patent/NO145881C/no unknown
- 1980-11-06 NO NO803336A patent/NO146431C/no unknown
-
1981
- 1981-04-22 CA CA375,997A patent/CA1130301A/en not_active Expired
-
1983
- 1983-04-19 SE SE8302173A patent/SE456992B/sv not_active IP Right Cessation
- 1983-04-19 SE SE8302172A patent/SE458605B/sv not_active IP Right Cessation
- 1983-04-19 SE SE8302171A patent/SE452155B/sv not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AT356078B (de) | Verfahren zur herstellung neuer acetohydroxam- saeuren und deren salze | |
AT352736B (de) | Verfahren zur herstellung neuer chinazolon- derivate und ihrer salze | |
AT363079B (de) | Verfahren zur herstellung neuer heterocyclischer 1-aryloxy-2-hydroxy-3-alkylenaminopropane und von deren salzen | |
AT377254B (de) | Verfahren zur herstellung neuer substituierter pyrrolidine und deren salzen | |
AT372946B (de) | Verfahren zur herstellung neuer bis-aminopyridine und deren salze | |
AT350737B (de) | Verfahren zur herstellung neuer n-tetrahydro- furfuryl-noroxymorphone und deren saeure- additionssalzen | |
ATA54480A (de) | Verfahren zur herstellung neuer benzopyranderivate und deren salze | |
AT366682B (de) | Verfahren zur herstellung neuer 3-fluor-6piperazinylmorphanthridine und ihrer saeureadditionssalze | |
AT360513B (de) | Verfahren zur herstellung neuer dimerer indol- -dihydroindol-carboxamide und ihrer salze | |
ATA246077A (de) | Verfahren zur herstellung neuer polyjodierter sisophthalsaeureamide und deren salzen | |
ATA622077A (de) | Verfahren zur herstellung neuer pyridobenzo- diazepinone und ihrer salze | |
ATA342176A (de) | Verfahren zur herstellung neuer 2-imidazolyl- chinazoline und ihrer salze | |
AT355014B (de) | Verfahren zur herstellung neuer 2-benzopyranon- derivate und ihrer salze | |
ATA265579A (de) | Verfahren zur herstellung neuer substituierter aethanolamine und deren salzen | |
AT350058B (de) | Verfahren zur herstellung neuer phthalazinon- und chinazolinonaralkylamine und deren salzen | |
ATA407977A (de) | Verfahren zur herstellung neuer hydrazinopyridazinderivate und deren salzen | |
AT369738B (de) | Verfahren zur herstellung neuer thiodibenzoxepine und deren saeureadditionssalze | |
AT374800B (de) | Verfahren zur herstellung neuer guanidinothiazole und von deren salzen | |
AT358193B (de) | Verfahren zur herstellung neuer n-tetrahydro- furfuryl-noroxymorphone und deren saeure- additionssalzen | |
AT374178B (de) | Verfahren zur herstellung neuer indolderivate und deren salzen | |
ATA224581A (de) | Verfahren zur herstellung neuer phthalazin-4ylessigsaeuren und deren salze | |
ATA29180A (de) | Verfahren zur herstellung neuer o-aryl-nphosphonmethylglycinnitrile bzw. deren sauren und alkalischen salzen | |
ATA338079A (de) | Verfahren zur herstellung neuer 1-amino-2- -hydroxy-3-heterocyclyloxy-progane und ihrer salze | |
AT355582B (de) | Verfahren zur herstellung neuer pyridobenzo- diazepinone und ihrer salze | |
ATA8479A (de) | Verfahren zur herstellung neuer chinazolon- derivate und ihrer salze |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |